Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-17-023222
Filing Date
2017-04-28
Accepted
2017-04-28 16:16:56
Documents
7
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A v465541_10ka.htm 10-K/A 394291
2 EXHIBIT 10.31 v465541_ex10-31.htm EX-10.31 319369
3 EXHIBIT 10.32 v465541_ex10-32.htm EX-10.32 82248
4 EXHIBIT 10.34 v465541_ex10-34.htm EX-10.34 83687
5 EXHIBIT 10.35 v465541_ex10-35.htm EX-10.35 98194
6 EXHIBIT 31.5 v465541_ex31-5.htm EX-31.5 3832
7 EXHIBIT 31.6 v465541_ex31-6.htm EX-31.6 3875
  Complete submission text file 0001144204-17-023222.txt   986599
Mailing Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

EIN.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36150 | Film No.: 17795772
SIC: 8731 Services-Commercial Physical & Biological Research